ArticleiScience2026
Multimodal-multiscale hybrid fusion network for automated esophageal cancer diagnosis.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate and early diagnosis of esophageal cancer (EC) remains challenging due to heterogeneous imaging characteristics and the complexity of integrating multimodal data. This study proposes a multimodal-multiscale hybrid fusion network (MHF-Net), which combines domain-driven handcrafted features (HFs) and deep multiscale features (DFs) from multimodal data for the automated diagnosis of EC. MHF-Net uses a dilated-inception block to extract multiscale representations at varied dilation rates and concatenates these DF with domain-specific features via dense connections. A convolutional block attention module further refined spatial and channel-wise features, leveraging global average pooling. The grasshopper optimization algorithm optimized fusion weights and hyperparameters, enhancing hybrid feature integration and overall model robustness. Evaluated across five diverse datasets, MHF-Net achieves state-of-the-art performance (accuracy = 0.970 ± 0.014; F1 score = 0.960 ± 0.017). This study demonstrates clinical applicability with strong potential for future enhancement through the integration of multimodal biomarkers for enhanced diagnostic accuracy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.